Login / Signup

Barriers to enrollment in clinical trials of patients with aggressive B-Cell NHL that progressed after CAR T-cell therapy.

Evandro D BezerraMadiha IqbalJavier MunozArushi KhuranaYucai WangMatthew John MaurerRadhika BansalMatthew HathcokN Nora BennaniHemant S MurthyAllison C RosenthalJonas PaludoJose C Villasboas BisnetoPatrick B JohnstonThomas M HabermannStephen M AnsellJanuario E CastroThomas E WitzigMohamed A Kharfan-DabajaGrzegorz S NowakowskiYi Lin
Published in: Blood advances (2022)
Keyphrases
  • cell therapy
  • clinical trial
  • stem cells
  • health insurance
  • mesenchymal stem cells
  • phase ii
  • affordable care act
  • open label
  • phase iii
  • double blind
  • randomized controlled trial
  • healthcare